Latest news
VistaGen Granted Nasdaq Extension to Regain Bid Compliance - The Globe and MailThe Globe and Mail · Thu, 06 Aug 2026 21:06:00 GMTMangoceuticals Wins Nasdaq Extension Amid Nuclea Deal Progress - The Globe and MailThe Globe and Mail · Wed, 05 Aug 2026 21:22:00 GMTVistagen Therapeutics (NASDAQ: VTGN) granted 180-day Nasdaq bid-price extension - Stock TitanStock Titan · Wed, 05 Aug 2026 20:05:55 GMTMango Granted 180-Day Nasdaq Extension to Regain $1.00 Minimum Bid Price - TradingViewTradingView · Tue, 04 Aug 2026 20:13:01 GMTMangoceuticals Granted 180-Day Extension by Nasdaq to - GlobeNewswireGlobeNewswire · Tue, 04 Aug 2026 20:05:00 GMTMangoceuticals Has Until Feb. 1, 2027 to Meet Nasdaq's $1 Bid Rule - Stock TitanStock Titan · Tue, 04 Aug 2026 20:05:00 GMTUS Market Close: Three Major Indices Extend Losses After Fed Meeting; Nasdaq Composite Index Falls for Sixth Day as PHLX Semiconductor Index Drops Over 5%; Memory Stocks Lead Declines While Software Stocks Find Support; Micron Tumbles Over 10 - TradingKeyTradingKey · Wed, 29 Jul 2026 07:00:00 GMTWall Street Highlights: S&P 500, Nasdaq Erase Gains As Chipmakers Extend Losses To Third Day - NDTV ProfitNDTV Profit · Tue, 28 Jul 2026 07:00:00 GMT